Trimethyl phosphite → [5-(2-Ethylbenzoimidazol-1-yl)-7-morpholin-4-ylthiazolo[5,4-d]pyrimidin-2-ylmethyl]phosphonic acid dimethyl ester
Reaction equation
Br[CH2:2][C:3]1[S:4][C:5]2[N:6]=[C:7]([N:18]3[C:22]4[CH:23]=[CH:24][CH:25]=[CH:26][C:21]=4[N:20]=[C:19]3[CH2:27][CH3:28])[N:8]=[C:9]([N:12]3[CH2:17][CH2:16][O:15][CH2:14][CH2:13]3)[C:10]=2[N:11]=1.[CH3:29][O:30][P:31]([O:34]C)[O:32][CH3:33]>>[CH3:29][O:30][P:31]([CH2:2][C:3]1[S:4][C:5]2[N:6]=[C:7]([N:18]3[C:22]4[CH:23]=[CH:24][CH:25]=[CH:26][C:21]=4[N:20]=[C:19]3[CH2:27][CH3:28])[N:8]=[C:9]([N:12]3[CH2:17][CH2:16][O:15][CH2:14][CH2:13]3)[C:10]=2[N:11]=1)(=[O:34])[O:32][CH3:33]Participants
3
Conditions
- Temperature
- 120 °C
Procedure
A mixture of 2-bromomethyl-5-(2-ethylbenzoimidazol-1-yl)-7-morpholin-4-ylthiazolo[5,4-d]pyrimidine (670 mg, 1.46 mmol) in trimethylphosphite (10 mL) was heated to reflux (120° C.) for 1 h then concentrated in vacuo. The resulting residue was purified by column chromatography (Si—PCC, MeOH:DCM, 0-2%) then (Si—PCC, MeOH:EtOAc, 0-5%) affording the title compound as a yellow solid (620 mg, 87%)._LCMS (method H): RT 2.46 min, [M+H]+ 489.3
Workup
- temperaturewas heated
- concentrationthen concentrated in vacuo
- customThe resulting residue was purified by column chromatography (Si—PCC, MeOH:DCM, 0-2%)
Sources & evidence
- ORD record
- ord-6eed172d0dca4c4fb713fc570fac5008
- Source dataset
- uspto-grants-2012_05
- Patent number
- US08173650B2
Reaction notes
Loading…